Please select the option that best describes you:
What is your approach to long-term immunosuppression in patients with Adult Onset Stills Disease?
Answer from: at Community Practice
For persistent or recurring disease flares, IL-1 blockers (canakinumab or anakinra).
Sign In or Register to read more